Advocacy intelligence hub — real-time data for patient organizations
University of Birmingham — NA
Zhuhai Trinomab Pharmaceutical Co., Ltd.
Lanzhou Institute of Biological Products Co., Ltd — PHASE1
Zhuhai Trinomab Pharmaceutical Co., Ltd.
Sinovac Life Sciences Co., Ltd. — PHASE1, PHASE2
Genrix (Shanghai) Biopharmaceutical Co., Ltd. — PHASE3
Changchun BCHT Biotechnology Co. — EARLY_PHASE1
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Bertrand Debaene, MD phD
CHU de Poitiers FRANCE
General Manager
Tanabe Pharma Corporation
Robert Laumbach, MD, MD
Rutgers, The State University of New Jersey
📍 PISCATAWAY, NJ
Hal Landy, MD, M.D
Valerion Therapeutics, LLC
📍 DOVER, MA
Mark Ballow, MD, MD
Children's Hospital of Buffalo
📍 TAMPA, FL
Shiguang Lei
Guizhou Center for Disease Control and Prevention